promoter drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (6)
Papers in which this entity is mentioned.
- Nanopore-based cell-free DNA fragmentation and methylation profiles from the cerebral spinal fluid of patients with lung cancer brain metastases. (2025)
- Sequence modeling and design from molecular to genome scale with Evo. (2024)
- Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. (2021)
- Driver Fusions and Their Implications in the Development and Treatment of Human Cancers. (2018)
- Nanopore Sequencing Reveals High-Resolution Structural Variation in the Cancer Genome (2017)
- Landscape of transcription in human cells. (2012)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| promoter | drug | 10 | 10 |
| promoter region | drug | 6 | 7 |